Awiqli® FlexTouch Pen for Adults With Diabetes

Awiqli FlexTouch Pen is a long-acting insulin designed for once-weekly dosing. It may lower out-of-pocket burden for people paying without insurance. This page explains safe-use basics, plus ordering steps that Ships from Canada to US.

What Awiqli Is and How It Works

Awiqli® is a prescription basal insulin (background insulin) used to help control blood glucose. Border Free Health connects U.S. patients with licensed Canadian partner pharmacies; prescriptions are verified with prescribers before dispensing.. Basal insulin supports steadier levels between meals and overnight.

This treatment contains insulin icodec FlexTouch pen for subcutaneous injection. It is formulated to work slowly and last longer than daily basal options. The goal is smoother fasting glucose control with fewer injection days.

For a plain-language overview of insulin types, read Types Of Insulin. That guide explains basal versus rapid acting insulin and common use patterns.

Who It’s For

This medicine is generally used for adults with diabetes mellitus who need basal insulin support. It may be used alone or alongside other glucose-lowering medicines, depending on the regimen. Some people also need mealtime insulin for post-meal control.

It is not a substitute for emergency care of severe hyperglycemia. It is typically not used for diabetic ketoacidosis, and it is not delivered by an insulin pump. Avoid use if there is a known allergy to ingredients in the product.

People with frequent severe hypoglycaemia (low blood sugar) need careful review before switching therapies. Extra caution is also common in advanced kidney or liver disease. Pregnancy and breastfeeding decisions should follow prescriber guidance and local labeling.

Dosage and Usage

Dosing is once per week, on the same day each week. A prescriber sets the starting dose and titration plan based on prior insulin exposure, glucose logs, and risk factors. Dose changes should follow the official product information.

The injection is given under the skin of the abdomen, thigh, or upper arm. Rotate sites to reduce lipohypertrophy (fatty lumping under the skin) that can disrupt absorption. Avoid injecting into areas that are bruised, scarred, hard, or tender.

Use the pen exactly as instructed in the device guide. New needles are typically used for each injection, and a short flow check is often recommended before dosing. Do not share pens, even with a new needle.

Strengths and Forms

This product is supplied as a prefilled, multi-dose injection pen. Awiqli FlexTouch 100 U/mL is commonly listed in a 3 mL presentation. Carton quantities can vary and may include a 5-pen pack.

Each pen has a dose window and a dial for setting the prescribed units. Availability may differ by region and current supplier stock. Listing details on the product page reflect the most current packaging information.

Missed Dose and Timing

Weekly dosing makes timing important, especially during travel or schedule changes. When a dose is missed, follow the instructions in the product leaflet or the prescriber’s plan. Doubling up doses can raise hypoglycemia risk.

In many weekly regimens, the missed dose is taken as soon as remembered if there is enough time before the next scheduled dose. If the next dose day is close, the safer option is often to skip and resume the usual schedule. Confirm the exact rule in the official labeling for this product.

Storage and Travel Basics

Unopened insulin pens are commonly stored in a refrigerator and protected from light. Do not freeze insulin, and discard any pen that has been frozen. Keep away from direct heat sources like car dashboards or sunny windows.

Many in-use pens can be kept at room temperature for a limited time, but the allowed duration differs by product. Always confirm the specific “in-use” window printed on the carton and leaflet. Cap placement helps protect the solution from light.

For travel, keep supplies in a carry-on bag and pack extra needles. Airport screening rules can change, so keep the pharmacy label with the pen. Borderfreehealth uses temperature-controlled handling when required.

Pen Handling and Sharps Disposal

Attach a new compatible pen needle before each injection, then remove the outer and inner needle caps. Follow the pen guide to prime or perform a flow check so the pen is ready. Dial the prescribed dose only after the pen is prepared.

Inject into a clean site and keep the needle in place briefly to help deliver the full dose. Remove the needle right after the injection, then recap using the outer cap and dispose of it safely. Storing the pen with a needle attached can lead to leakage and air entry.

Used needles and lancets belong in an FDA-cleared sharps container or a heavy-duty household container with a tight lid, if permitted locally. Follow local rules for drop-off or household hazardous waste. Keep sharps away from children and pets.

Benefits

The main convenience feature is fewer injection days across the month. For many regimens, a weekly insulin pen can reduce missed basal doses linked to busy schedules. It may also simplify planning around work and travel.

This insulin provides background coverage rather than meal-time spikes. That can help target fasting glucose when paired with food choices, activity, and other medicines. Glucose monitoring still matters, especially during dose adjustments.

Side Effects and Safety

Insulin can cause low blood sugar, and the risk is higher with reduced food intake, unplanned activity, or dosing errors. Extra monitoring is often needed when used with sulfonylureas or other medicines that lower glucose. Injection technique and site rotation also affect day-to-day stability.

• Low blood sugar: shakiness, sweating, confusion
• Injection-site reactions: redness, itching, swelling
• Weight gain: can occur with insulin therapy
• Fluid retention: swelling in ankles or feet
• Skin changes: lumps with repeated sites

Serious reactions are uncommon but need urgent attention. These include severe hypoglycemia, allergic reactions with trouble breathing, and very low potassium (hypokalemia) that can affect the heartbeat. Insulin used with thiazolidinediones can worsen heart failure in some people, so clinicians monitor for edema and shortness of breath.

Drug Interactions and Cautions

Many medicines can change glucose needs. Corticosteroids, some antipsychotics, and certain diuretics can raise blood glucose, while other diabetes medicines can increase hypoglycemia risk when combined. Alcohol can also make lows harder to predict.

Beta blockers may mask some warning signs of hypoglycemia, such as tremor or palpitations. Illness, reduced appetite, and changes in kidney function can also alter insulin sensitivity. Review the full medication list with a clinician and pharmacist before starting or switching.

What to Expect Over Time

Glucose patterns may shift as the weekly dose is adjusted. Early changes are often seen in fasting readings, while longer-term control is assessed with A1C and overall trends. A consistent injection day helps keep exposure steady week to week.

During transitions from daily basal insulin, clinicians often increase monitoring and refine the plan. Keep glucose logs, note meals and activity, and report recurring lows or highs. Small technique issues, like repeated sites, can look like a dose problem.

People using continuous glucose monitoring may notice fewer basal injections to track. Those using fingersticks may need extra checks around dose changes. For broader comparisons of injectable options, see Ozempic Vs Insulin.

Compare With Alternatives

Some people prefer a daily basal insulin with long experience and flexible titration. Options offered include Toujeo® DoubleStar Pens and Basaglar® KwikPen. These products are typically taken once daily rather than once weekly.

Another approach combines a basal insulin with a GLP-1 receptor agonist in one device, such as Xultophy. The best fit depends on A1C goals, hypoglycemia history, weight considerations, and access. A prescriber can advise on switching and monitoring needs.

Pricing and Access

For people comparing pharmacy options, the listing supports a quick check of the buy insulin icodec pen process and required prescription steps. Canadian pricing can be helpful for cash-pay shoppers managing ongoing therapy. US delivery from Canada is available for eligible orders.

To view the current checkout total, select the package size and proceed to the cart. For additional offers that may apply, visit Promotions once before completing checkout. Encrypted checkout protects information during purchase and account actions.

Refill planning matters for weekly dosing. Setting reminders and ordering before supplies run low can reduce gaps. A pharmacist may also confirm needle compatibility and supply needs.

Availability and Substitutions

Stock can change based on manufacturer supply and regional allocation. If the selected package is unavailable, a prescriber may recommend a different basal insulin or a different device format. Substitutions should only occur when the prescription and product match.

When a change is needed, share recent glucose logs and the current dosing schedule with the clinician. That context helps reduce transition errors. Pharmacy staff can also confirm what is currently obtainable.

Patient Suitability and Cost-Saving Tips

The weekly schedule may suit people who miss daily basal doses. It may be less suitable for those who need frequent basal adjustments or who have unpredictable meal patterns. A clinician weighs those factors alongside safety history.

For budgeting, Awiqli cost without insurance can vary by package size and refill cadence. Consider a multi-month supply when permitted, since it can reduce reorder frequency. Pair the pen with supplies from the Diabetes Care category, such as pen needles and glucose testing tools.

Education reduces waste and helps avoid preventable lows. Reviewing injection technique and site rotation once per month can be useful. For ongoing reading, browse Type 2 Diabetes Posts and condition basics in Type 2 Diabetes.

Questions to Ask Your Clinician

• Weekly schedule: best injection day for routine
• Switching plan: how to transition safely
• Monitoring plan: when to check glucose
• Low glucose: how to treat episodes
• Other medicines: interaction and combo risks
• Travel: managing time zone changes

Authoritative Sources

For Canadian product monograph details, check Health Canada Drug Product Database.

For EU-reviewed safety information, see European Medicines Agency EPAR Index.

For manufacturer background, review Novo Nordisk.

Place an order on Borderfreehealth with a valid prescription for review and prompt, express shipping.

This content is for informational purposes only and is not a substitute for professional medical advice.